curcumin. As part of our research in this area, the title compound was synthesized. The C21H20O3 molecule contains three rings. The bond lengths within phenyl rings are between 1.371(2) Â and 1.405(2) Â, which highlights the aromatic character. The molecule has crystallographic two-fold rotation symmetry and shows an £-configuration of the central olefînic bonds. The two independent planar benzene ring systems are essentially indentical, and the central cyclopentanone ring are almost coplanar with the two benzene rings [dihedral angle = 4.2(2)°]. TTie two methoxyl groups attached to atoms C9 and C9A are located on different sides of the CI =01 double bond, as reflected by the torsion angles
Discussion
The title compound is a biologically active derivative of curcumin. During the last two decades, numerous studies have shown that curcumin has a variety of biological and pharmacological activities such as anti-carcinogen, immuno-modulation, anti-oxidant, anti-angiogenesis, anti-inflammation and chemoprevention [2] [3] [4] [5] . However, pre-clinical and clinical studies have found that the potential beneficial effects of curcumin on various disease preventions and treatments are limited by its poor pharmacokinetic properties [6, 7] . It is suggested that the presence of the methylene group and /3-diketone moiety contributes to the instability of curcumin under physiological conditions [8, 9] . In our previous study, a series of mono-carbonyl analogues of curcumin were designed by deleting the reactive /?-diketone moiety and synthesized [10-13]. p a rt of bisbenzylidene cyclopentanone derivatives showed stronger bio-activities than 
